← Open Payments lookup

MOLLY WILLIS: Open Payments

NPI 1275921264 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$869 in 41 payments from 10 companies in 2025. Trend: 2023 $1,500 · 2024 $1,284 · 2025 $869

Food & beverage: $869
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$310
E.R. Squibb & Sons, L.L.C.7$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
Otsuka America Pharmaceutical, Inc.4$79
Teva Pharmaceuticals USA, Inc.3$66
Alkermes, Inc.3$54
Janssen Pharmaceuticals, Inc2$37
ABBVIE INC.2$35
Vanda Pharmaceuticals Inc.1$28
Lundbeck LLC1$23

Products named: INGREZZA, COBENFY, CAPLYTA, UZEDY, ABILIFY ASIMTUFII, REXULTI, VIVITROL, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.